Medpace price target raised to $600 from $450 at Barclays
Analyst target changes matter most when the new target creates a material gap versus current price or confirms a recent catalyst.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Analyst target changes matter most when the new target creates a material gap versus current price or confirms a recent catalyst.
What happened, with direct paths to the underlying reporting
Barclays raises Medpace (MEDP) price target to $600 from $450; current price around $605.82.
Target: $600
Posted price: $605.82
Analyst firm: Barclays
Analyst: Luke Sergott
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.